BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Adipose tissue
,
Autoimmunity
,
Doxorubicin
,
rs4950928
,
SLC12A1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Sm D1
Summary
General Info
Curated Studies
Most Correlated Studies
Primitive streak, endoderm progenitor and endoderm cells differentiated from iPSC of donors
Testes from P14 rats treated in vivo for 4d with FSH neutralizing antibody or control IgG
Explore Curated Studies Results
Literature
Most Relevant Literature
Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP me…
Novel blended SNRPE-related spliceosomopathy phenotype characterized by microcephaly and congenital …
Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and divers…
SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy th…
Low-level mosaic trisomy 13 at amniocentesis in a pregnancy associated with a positive NIPT result s…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer P…
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ